Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin intra-articular injection for thumb carpometacarpal osteoarthritis pain
2020-002127-10Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Rhizarthrosis comparing Xeomin intra-articular injection with Placebo intra-articular injection (2 arms). Primary endpoint: Pain assessment at 3 months. Started Jun 2020; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on 2020-002127-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002127-10.